Pharmanutra Notice of Filing of the List for the Appointment of the Board of Statutory Auditors
Unknown
—
MONRIF
Unknown
—
Banca Popolare dell'Alto Adige SPA
Unknown
—
NEXI
Unknown
—
Eles Semiconductor Equipment CS
Unknown
—
KALEON SPA
Unknown
—
Moltiply Group
Unknown
—
LEONARDO
Unknown
—
PIRELLI & C.
Unknown
—
NEXI UPDATE ON THE EXECUTION OF THE SHARE BUYBACK PROGRAMME (FROM JUNE 16 TO JUNE 20, 2025)
Unknown
—
NEXI UPDATE ON THE EXECUTION OF THE SHARE BUYBACK PROGRAMME (FROM JULY 14 TO JULY 18, 2025)
Unknown
—
PHARMANUTRA
Unknown
—
Bestbe Holding
Unknown
—
ITALGAS
Unknown
—
Fervi Comunicazione Internal Dealing
Unknown
—
ITALGAS
Unknown
—
Fincantieri Fincantieri
Unknown
—
PRYSMIAN
Unknown
—
MONDO TV
Unknown
—
MEDIOBANCA
Unknown
—
CIR SPA
Unknown
—
IPI SPA
Unknown
—
FERRETTI SPA
Unknown
—
KALEON SPA
Unknown
—
CIR
Unknown
—
IPI
Unknown
—
TINEXTA
Unknown
—
Banca Popolare dell'Alto Adige SPA
Unknown
—
VALICA SPA
Unknown
—
Banca Popolare dell'Alto Adige SPA
Unknown
—
AVIO SPA
Unknown
—
Garofalo Health Care Garofalo Health Care S.p.a.: Standard Ethics Conferma IL Rating ESG di Breve e Medio/lungo Termine / Standard Ethics Confirms Short-Term and Medium/long-Term ESG Ratings
Unknown
—
PIAGGIO & C.
Unknown
—
OPS ECOM
Unknown
—
TRAWELL CO
Unknown
—
PIAGGIO & C. CS GRUPPO PIAGGIO - PROGETTO DI BILANCIO 2023
Unknown
—
UNIPOL
Unknown
—
OSAI AUTOMATION SYSTEM CS ITAENG OSAI A.S. S.P.A. SB IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2023
Unknown
—
DIRECTA SIM
Unknown
—
Franchi Umberto Marmi FUM
Unknown
—
MAPS MAPS GROUP: RESILIENCE AND RECURRING REVENUES DRIVE GROWTH IN 2023 – ERRATA CORRIGE
Unknown
—
PHARMANUTRA
Unknown
—
BANCA GENERALI PR
Unknown
—
Piaggio & C. Gruppo Piaggio: Consiglio di Amministrazione
Unknown
—
Banca Popolare dell'Alto Adige SPA
Unknown
—
PIAGGIO & C.
Unknown
—
KALEON SPA
Unknown
—
FERRETTI SPA
Unknown
—
Moltiply Group SPA
Unknown
—
KALEON SPA
Unknown
—
Pirelli & C. SPA
Unknown
—
Equita Group SPA
Unknown
—
NEXI AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE (DAL 2 AL 6 GIUGNO 2025)